(Q46499691)

English

High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception

scientific article published on 19 May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception (English)

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

hyperandrogenism

1 reference

based on heuristic

inferred from title

author name string

Lourdes Ibáñez

1

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

Adriana Maria Jaramillo

2

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

Angela Ferrer

3

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

Francis de Zegher

4

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

language of work or name

0 references

publication date

19 May 2005

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

Human Reproduction

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

20

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

9

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

2457-2462

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Increased C-reactive protein levels in the polycystic ovary syndrome: a marker of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Inflammation: the link between insulin resistance, obesity and diabetes

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Current concepts in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Insulin resistance and chronic cardiovascular inflammatory syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Clinical assessment of body hair growth in women

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Nontraditional risk factors for cardiovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Early menarche and subclinical ovarian hyperandrogenism in girls with reduced adult height after low birth weight

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide.

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Genotyping Steroid 21-Hydroxylase Deficiency: Hormonal Reference Data*

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

An observational study of Yasmin in the management of women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Endothelial inflammation in insulin resistance

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Obesity is associated with macrophage accumulation in adipose tissue

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEI072

21 January 2018

Identifiers

10.1093/HUMREP/DEI072

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

1 reference

Europe PubMed Central

22 December 2017

http://europepmc.org/abstract/MED/15905296

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46499691&oldid=2114458002"